January 26, 2022
Taiho Pharmaceutical on January 24 issued the latest supply update for the anticancer agent Abraxane IV Infusion 100 mg (paclitaxel), which is currently under shipment controls, saying that its supply is expected to continue until around July in Japan. In...read more